Intercellular communication is a key feature of cancer progression and metastasis.
Extracellular vesicles (EVs) are generated by all cells, including cancer cells, and recent …

Extracellular vesicles (EVs) are diverse nanoparticles with large heterogeneity in size and
molecular composition. Although this heterogeneity provides high diagnostic value for liquid …

Background: The ability to isolate extracellular vesicles (EVs) from blood is vital in the
development of EVs as disease biomarkers. Both serum and plasma can be used, but few …

Extracellular vesicles (EVs) occur in a variety of bodily fluids and have gained recent
attraction as natural materials due to their bioactive surfaces, internal cargo, and role in …

Nanotechnology profoundly affects the advancement of medicine. Limitations in diagnosing
and treating cancer and chronic diseases promote the growth of nanomedicine. However …

Extracellular vesicles (EVs) are gaining ground as next-generation drug delivery modalities.
Genetic fusion of the protein of interest to a scaffold protein with high EV-sorting ability …

While the field of precision oncology is rapidly expanding and more targeted options are
revolutionizing cancer treatment paradigms, therapeutic resistance particularly to …

Development of molecular diagnostics for lung cancer stratification and monitoring is crucial
for the rational planning and timely adjustment of treatments to improve clinical outcomes. In …

Liquid biopsy has been rapidly developed in recent years due to its advantages of non-
invasiveness and real-time sampling in cancer prognosis and diagnosis. Exosomes are …

Cell-derived extracellular vesicles (EVs) are currently in the limelight as potential disease
biomarkers. The promise of EV-based liquid biopsy resides in the identification of specific …